Navigation Links
Only the Breast Announces Innovative Milk Banking Program and Partnership
Date:10/23/2013

RENO, Nev., Oct. 23, 2013 /PRNewswire-iReach/ -- Only The Breast (OTB)   is founded on the premise that donors have a key role to play in helping solve the breast milk shortage.  As part of OTB's effort to support access to safe and responsibly sourced donor milk, we have made the decision to refocus OTB activities.

OTB is working hard to develop milk bank partnerships that empower donating women and their families, put into place robust donor screening programs, and embrace professional milk processing measures. We feel that this decision will better enable OTB to continue its core mission as advocates for both donating mothers and babies in need.

As a result of this decision we will be phasing out our breast milk classified ads service and will completely remove them once we can guarantee a smooth transition. This decision will impact all OTB activities related to informal milk sharing.

While this decision will come as a disappointment to some, OTB feels compelled to act as we have become increasingly concerned about the need for greater focus on the safety and interests of donating mothers, as well as the ongoing shortage of high quality donor milk for babies in need. We are not willing to accept that the current breast milk shortage is inevitable. The primary reason donors come to OTB is so they can help babies while receiving fair compensation for their milk. OTB has thousands of donors and millions of ounces flowing through it annually and we feel our decision will ultimately help address this situation.

Only the Breast is pleased to announce the Milk For Babies Reimbursement Program which will provide life-saving breast milk for use in hospitals and clinical settings and give donors the assurance that they will receive fair compensation. Donors will be fully screened, tested and instructed on safe handling methods and all milk will be professionally processed.

OTB is pleased to announce a promising partnership with Medolac Laboratories that will make it possible for us to screen potential donors and process donor milk collected through the Milk For Babies program. Glenn Snow, Co-Founder of Only the Breast stated, "We are extremely pleased with this partnership, which reflects our commitment to improve the safety of donor milk while improving access to babies in need."

Doug Hawkins, Senior Vice President of Corporate Affairs Medolac Laboratories stated, "We are pleased that OnlyTheBreast.com has made the decision to partner with us as we are passionate about donor and infant safety.  This decision will help advance our common interest in upholding the principles of ethical sourcing and build the trust and confidence necessary to secure sustainable and fair milk banking."  

About Only the Breast:  Only The Breast is the world's largest online breast milk donor community.  We provide a platform where mothers can reach babies in need with their excess breast milk. Our mission is to significantly increasing the amount of human breast milk available to babies while also serving the needs of the donating mothers. Only The Breast is a Nevada corporation headquartered at Reno, Nevada.
Media Contact: Glenn Snow, 775- 298-1222 Only The Breast, info@onlythebreast.com

About Medolac:  Medolac Laboratories develops innovative, adapted human milk products for clinical use, applying proprietary biopharmaceutical processing methods that preserve the immune components in human milk. Our vision is to offer accessible, safe, high quality nutritional care for critically ill infants in need. Medolac Laboratories is a Delaware corporation (Neolac Inc. dba Medolac) headquartered at Lake Oswego, Oregon in the Pacific Northwest of the United States.
Media Contact: Yvonne Arroyo, Medolac Laboratories, 866-599-7740, yvonne.arroyo@medolac.com

Media Contact: Glenn Snow, Only The Breast, 775-298-1222, Info@onlythebreast.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Only The Breast
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Data Presented For ENMD-2076 In Preclinical Models Of Triple-Negative Breast Cancer
2. American Society of Breast Surgeons Release MammoSite Breast Brachytherapy Registry Trial Final Results
3. Hologic to Mark Start of Breast Cancer Awareness Month with NASDAQ Opening Bell Ceremony
4. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
5. Studies Show Excellent Outcomes With Strut-Based Breast Brachytherapy
6. 15 October 2013 Breast Health Day: From Spain to Tajikistan, from Israel to Sweden, a Day Dedicated to the Breast Health of Women Worldwide
7. Syndaxs Entinostat Receives Breakthrough Therapy Designation from FDA for Treatment of Advanced Breast Cancer
8. Multiple International Breast Cancer Guidelines Confirm Use of Agendia Tests for Prognostic, Predictive Information in Cancer Treatment Decisions
9. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials to be Presented at the 2013 San Antonio Breast Cancer Conference
10. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
11. Global Breast Pumps Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... 2016 RnRMarketResearch.com adds "Asthma - ... analysis of Asthma therapy at various stages, therapeutics assessment ... administration (RoA) and molecule type, along with latest updates, ... key players involved in the therapeutic development for Asthma ... Complete report on H1 2016 pipeline review of ...
(Date:5/30/2016)... 2016 According to a ... Market by Type (Stability, Raw Materials, Method Validation, ... (Pharmaceutical Companies, Medical Device Companies) - Global Forecast ... healthy growth during the last decade and is ... between 2016 and 2021 to reach USD 4.13 ...
(Date:5/30/2016)... - DCGI grants limited approval to market Stempeucel® product for ... Stempeucel® becomes 5th off-the-shelf Stem cell product to be approved by ... Disease (also known as Thromboangiitis Obliterans) is a major unmet medical ... - Prevalence of Buerger,s Disease is estimated to be 1,000,000 in ... the European Community & USA ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... May 31, 2016 , ... Interest is on the rise ... and as an orthogonal tool for RNAi hit validation. A key reason may be ... RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed formats. , ...
(Date:5/31/2016)... ... May 31, 2016 , ... In a recent interview on The Greenburgh Report ... Rochelle, NY-based WVOX (1460 AM), leading medical insurance advocate Adria Goldman Gross ... “modern medical money maelstrom.” , During the interview with Mr. Feiner that aired ...
(Date:5/31/2016)... IL (PRWEB) , ... May 31, 2016 , ... ... multichannel marketing services firm and statement solutions provider, for the tenth ... in the May 2016 issue of Advertising Age, and SourceLink ranked eighteenth in ...
(Date:5/31/2016)... ... ... Super Powder, a supplement produced by Prox Formulas for providing protein ... to transform the nutritional supplement industry by providing a safe, natural approach to enhanced ... (BCAA), alkaline minerals, wheat grass, digestive enzymes, Omega 3’s, Vit D3, Vit A, B1, ...
(Date:5/30/2016)... ... May 30, 2016 , ... Zane Benefits, the leader ... an original infographic, " Health Benefits Reimbursement Compliance Timeline ." , The ... complies with various federal regulations and reforms. , Navigating the new health reforms ...
Breaking Medicine News(10 mins):